Schrödinger (SDGR) Revenue & Revenue Breakdown
Schrödinger Revenue Highlights
Latest Revenue (Y)
$216.67M
Latest Revenue (Q)
$47.33M
Main Segment (Y)
Drug Discovery Contribution
Main Geography (Y)
UNITED STATES
Schrödinger Revenue by Period
Schrödinger Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $216.67M | 19.73% |
| 2022-12-31 | $180.96M | 31.19% |
| 2021-12-31 | $137.93M | 27.60% |
| 2020-12-31 | $108.09M | 26.36% |
| 2019-12-31 | $85.54M | 28.37% |
| 2018-12-31 | $66.64M | 19.65% |
| 2017-12-31 | $55.69M | - |
Schrödinger generated $216.67M in revenue during NA 2023, up 19.73% compared to the previous quarter, and up 325.13% compared to the same period a year ago.
Schrödinger Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $47.33M | 29.33% |
| 2024-03-31 | $36.60M | -50.63% |
| 2023-12-31 | $74.13M | 74.13% |
| 2023-09-30 | $42.57M | 20.97% |
| 2023-06-30 | $35.19M | -45.68% |
| 2023-03-31 | $64.78M | 13.97% |
| 2022-12-31 | $56.84M | 53.71% |
| 2022-09-30 | $36.98M | -3.87% |
| 2022-06-30 | $38.47M | -20.95% |
| 2022-03-31 | $48.66M | 5.40% |
| 2021-12-31 | $46.17M | 54.67% |
| 2021-09-30 | $29.85M | 0.22% |
| 2021-06-30 | $29.78M | -7.29% |
| 2021-03-31 | $32.13M | -2.74% |
| 2020-12-31 | $33.03M | 28.05% |
| 2020-09-30 | $25.80M | 11.71% |
| 2020-06-30 | $23.09M | -11.78% |
| 2020-03-31 | $26.17M | 1.32% |
| 2019-12-31 | $25.83M | 29.42% |
| 2019-09-30 | $19.96M | 5.00% |
| 2019-06-30 | $19.01M | -8.35% |
| 2019-03-31 | $20.74M | 18.68% |
| 2018-12-31 | $17.48M | 34.51% |
| 2018-09-30 | $12.99M | - |
Schrödinger generated $47.33M in revenue during Q2 2024, up 29.33% compared to the previous quarter, and up 73.07% compared to the same period a year ago.
Schrödinger Revenue Breakdown
Schrödinger Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| Drug Discovery Contribution | $1.95M | - | - |
| Maintenance | - | $17.29M | $14.46M |
| Software Products And Services | - | $113.24M | $92.53M |
| Software Contribution | - | $1.00M | - |
| Revenue From Contract With Customer Before Software Contribution | - | $112.24M | - |
| Professional Services | - | $9.27M | $9.56M |
| On Premise Software | - | $74.60M | $58.31M |
| Hosted Software | - | $11.08M | $9.19M |
| Contribution | - | - | $1.00M |
| Revenue From Contract With Customer Before Contribution | - | - | $91.53M |
Schrödinger's latest annual revenue breakdown by segment (product or service), as of Dec 22: Drug Discovery Contribution (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Maintenance | $5.84M | $5.89M | $5.75M | $5.75M | $5.25M | $5.06M | $4.95M | $4.73M | $4.61M | $4.40M | $4.18M | $4.11M | $3.84M | $3.54M | $3.55M | $3.54M | - |
| On Premise Software | $18.76M | $17.62M | $13.81M | $19.94M | $33.63M | $12.58M | $16.59M | $21.69M | $27.30M | $15.50M | $14.45M | $17.36M | $16.54M | $15.06M | $11.11M | $15.60M | - |
| Software Products And Services | $35.40M | $33.41M | $29.58M | $32.21M | $8.10M | $24.67M | $30.01M | $33.08M | $38.56M | $24.28M | $24.05M | $26.34M | $24.96M | $22.86M | $20.90M | $23.81M | - |
| Contribution | - | - | $1.80M | - | $1.00M | - | $1.00M | - | - | $1.00M | - | - | - | - | - | - | - |
| Professional Services | $2.72M | $2.73M | $2.08M | $2.07M | $4.81M | $3.11M | $3.87M | $3.41M | $3.57M | $1.70M | $1.72M | $2.28M | $2.20M | $1.89M | $2.93M | $2.54M | - |
| Revenue From Contract With Customer Before Contribution | $35.40M | $33.41M | $27.10M | $24.67M | $29.01M | $24.28M | $23.05M | $24.96M | $22.86M | $19.90M | - | - | - | - | - | - | - |
| Hosted Software | $8.09M | $7.18M | $5.46M | $4.45M | $4.13M | $3.91M | $3.60M | $3.25M | $3.09M | $2.68M | $2.70M | $2.60M | $2.37M | $2.37M | $2.31M | $2.13M | - |
| Drug Discovery Contribution | - | - | - | $605.00K | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Drug Discovery Services Revenue From Contracts With Customers | - | - | - | - | $31.80M | $11.72M | $8.02M | - | - | - | - | - | - | - | - | - | - |
| Drug Discovery Services | - | - | - | - | $2.17M | $1.94M | $2.00M | $1.35M | - | - | - | - | - | - | - | - | - |
| Drug Discovery | - | - | - | - | $32.57M | $10.04M | $12.31M | $8.46M | - | - | - | - | - | - | - | - | - |
Schrödinger's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Software Products And Services (33.33%), Revenue From Contract With Customer Before Contribution (33.33%), On Premise Software (17.66%), Hosted Software (7.61%), Maintenance (5.50%), and Professional Services (2.56%).
Schrödinger Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| Europe | $33.05M | $27.81M | $24.37M |
| UNITED STATES | $123.56M | $90.40M | $60.74M |
| JAPAN | $10.47M | $8.56M | $14.56M |
| Non-US | $13.88M | - | - |
| Non Us | - | $11.16M | $8.43M |
Schrödinger's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (68.28%), Europe (18.26%), Non-US (7.67%), and JAPAN (5.79%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $7.80M | $7.20M | $3.76M | $4.83M | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $30.70M | $23.30M | $33.13M | $23.96M | $50.34M | $27.47M | $27.10M | $30.27M | $31.99M | $19.68M | $16.91M | $16.34M | $17.77M | $13.14M | $13.49M | - |
| APAC | $8.71M | $5.50M | $5.57M | $6.24M | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-US | $121.00K | $604.00K | $117.00K | $156.00K | $3.43M | $3.65M | - | - | - | - | - | - | - | - | - | - |
| Europe | - | - | - | - | $6.65M | $3.86M | $5.11M | $12.64M | $9.45M | $3.57M | $4.25M | $10.54M | $7.88M | $3.28M | $4.92M | $8.28M |
| JAPAN | - | - | - | - | $4.36M | $2.00M | $2.97M | $1.56M | $2.19M | $2.91M | $1.53M | $6.69M | $2.90M | $3.00M | $1.97M | - |
| Non Us | - | - | - | - | - | - | $3.29M | $4.19M | $2.53M | $2.54M | $2.95M | $3.14M | $2.12M | $1.85M | $2.03M | $2.44M |
| U S | - | - | - | - | - | - | - | - | - | $21.82M | - | - | - | - | - | - |
| J P | - | - | - | - | - | - | - | - | - | $1.92M | - | - | - | - | - | - |
Schrödinger's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (64.86%), APAC (18.40%), EMEA (16.49%), and Non-US (0.26%).
Schrödinger Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| GEHC | GE HealthCare | $19.55B | $4.84B |
| TDOC | Teladoc Health | $2.60B | $642.44M |
| VEEV | Veeva Systems | $2.36B | $676.18M |
| PGNY | Progyny | $1.09B | $304.09M |
| HQY | HealthEquity | $999.59M | $299.93M |
| TXG | 10x Genomics | $618.73M | $153.10M |
| DOCS | Doximity | $475.42M | $126.68M |
| ACCD | Accolade | $414.29M | $110.47M |
| CERT | Certara | $354.34M | $93.31M |
| SDGR | Schrödinger | $216.67M | $47.33M |
| AMWL | American Well | - | - |
SDGR Revenue FAQ
What is Schrödinger’s yearly revenue?
Schrödinger's yearly revenue for 2023 was $216.67M, representing an increase of 19.73% compared to 2022. The company's yearly revenue for 2022 was $180.96M, representing an increase of 31.19% compared to 2021. SDGR's yearly revenue for 2021 was $137.93M, representing an increase of 27.60% compared to 2020.
What is Schrödinger’s quarterly revenue?
Schrödinger's quarterly revenue for Q2 2024 was $47.33M, a 29.33% increase from the previous quarter (Q1 2024), and a 34.51% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $36.6M, a -50.63% decrease from the previous quarter (Q4 2023), and a -43.51% decrease year-over-year (Q1 2023). SDGR's quarterly revenue for Q4 2023 was $74.13M, a 74.13% increase from the previous quarter (Q3 2023), and a 30.40% increase year-over-year (Q4 2022).
What is Schrödinger’s revenue growth rate?
Schrödinger's revenue growth rate for the last 3 years (2021-2023) was 57.08%, and for the last 5 years (2019-2023) was 153.28%.
What are Schrödinger’s revenue streams?
Schrödinger's revenue streams in c 22 are Drug Discovery Contribution
What is Schrödinger’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Schrödinger was Drug Discovery Contribution. This segment made a revenue of $1.95M, representing 100.00% of the company's total revenue.